chr1-40281367-A-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_005857.5(ZMPSTE24):c.794A>G(p.Asn265Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_005857.5 missense
Scores
Clinical Significance
Conservation
Publications
- lethal restrictive dermopathyInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet
- mandibuloacral dysplasia with type B lipodystrophyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- restrictive dermopathy 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Hutchinson-Gilford progeria syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005857.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZMPSTE24 | NM_005857.5 | MANE Select | c.794A>G | p.Asn265Ser | missense | Exon 7 of 10 | NP_005848.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ZMPSTE24 | ENST00000372759.4 | TSL:1 MANE Select | c.794A>G | p.Asn265Ser | missense | Exon 7 of 10 | ENSP00000361845.3 | ||
| ZMPSTE24 | ENST00000674703.1 | n.*635A>G | non_coding_transcript_exon | Exon 8 of 11 | ENSP00000501674.1 | ||||
| ZMPSTE24 | ENST00000675754.1 | n.*536A>G | non_coding_transcript_exon | Exon 8 of 11 | ENSP00000502555.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251390 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461806Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 727200 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2Other:1
For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this missense change affects ZMPSTE24 function (PMID: 17152860, 22718200). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Not Available"). ClinVar contains an entry for this variant (Variation ID: 140540). This missense change has been observed in individual(s) with mandibuloacral dysplasia with lipodystrophy (PMID: 15937076, 17152860, 25629449, 30919593). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs281875371, gnomAD 0.003%). This sequence change replaces asparagine with serine at codon 265 of the ZMPSTE24 protein (p.Asn265Ser). There is a small physicochemical difference between asparagine and serine.
ZMPSTE24: PM3:Very Strong, PM2, PS3:Supporting
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at